1. Field of Invention
This present invention generally relates to medical devices and more particularly to implantable devices for monitoring internal pressure, e.g., intracranial pressure, of a living being.
2. Description of Related Art
Implantable sensors are important diagnostic devices which help measure physiological parameters that are difficult or even impossible to measure noninvasively. However, implantable devices pose several problems for the designer. They have to be biocompatible, so they do not harm the patient over a long or short term, and they cannot trigger physiological or patho-physiological reactions (e.g., immunological reactions) which can compromise their ability to perform measurements.
Another set of problems stems from engineering requirements. The stability requirements for the implantable sensor are more strict that those for the noninvasive devices since they cannot be calibrated at will, or at least, the calibration process is usually more challenging compared to other devices.
The long term implantable pressure sensors carry two inherent problems affecting their stability.
First, short term body temperature fluctuations change the internal temperature, thus changing the internal pressure. This pressure change affects the pressure differential between the internal pressure of the device and the external one (e.g., intracranial pressure, ICP). Another short term factor may include the change in the amount of gas inside the sensor body (e.g., gas absorption due to oxidation or gas release from materials inside the capsule). These types of changes can also add or subtract from forces acting on the transducer by changing forces acting on the membrane separating the inside of the sensor from the external environment.
Second, the natural body responses cause protein deposits on the outside surface of the device, thereby changing the effective stiffness of the membrane. This change in effective stiffness may change the sensitivity of the device or even entirely block the external pressure. This type of problem is usually associated with long term changes.
The above-listed problems (assuming that the membrane by itself does not generate any stress on the sensor regardless of the displacement, i.e., an ideal membrane) causes the output-input characteristic of the sensor to shift up or down (see
One of the physiological parameters which is difficult to measure noninvasively is ICP. ICP can be an important parameter in monitoring hydrocephalic patients, or traumatic brain injury (TBI) victims.
Since cerebrospinal fluid is enclosed in a semi closed system (i.e., the skull), the forces exerted by it are counterbalanced by a rigid structure of bones and, to some extent, by a semi rigid structure of the spinal channel. In a mechanical sense, there is no direct link (except for some small vessels which are difficult to utilize due to their anatomical nature) between the cerebrospinal fluid and the external environment. Thus, an implantable sensor outfitted with a reliable means of calibration would be a valuable addition to neurosurgical armamentarium.
Thus, there remains a need for an implantable pressure sensor that can account for these artifacts and provide a more accurate reading of the internal pressure to be measured.
All references cited herein are incorporated herein by reference in their entireties.
A pressure sensor that is implantable within a living being for detecting a pressure (e.g., intracranial pressure (ICP), blood pressure, lung pressure, etc.) present at a location wherein the pressure sensor is implanted is disclosed. The implantable pressure sensor comprises: a housing comprising one side formed by a flexible membrane; wherein the housing further comprises sensor electronics including a force transducer which is in contact with the membrane for detecting flexing of the flexible membrane when the flexible membrane is exposed to the pressure present at the location; the sensor electronics further comprise at least one capacitor coupled to the flexible membrane, wherein the at least one capacitor applies a known force to the membrane, detected by the force transducer, when the at least one capacitor is energized by the sensor electronics; and wherein the known force is used to calibrate for a stiffness associated with the flexible membrane in measuring the pressure at the location.
A pressure sensor that is implantable within a living being for detecting a pressure (e.g., intracranial pressure (ICP), blood pressure, lung pressure, etc.) present at a location wherein the pressure sensor is implanted is disclosed. The implantable pressure sensor comprises: a housing comprising one side formed by a flexible membrane; the housing further comprises sensor electronics including a displaceable force transducer in contact with the membrane for detecting flexing of the flexible membrane when the flexible membrane is exposed to the pressure present at the location; the sensor electronics further comprise a calibrating force member that applies a known calibrating force to the force transducer when the force transducer is displaced away from the flexible membrane; and wherein the known force is used, along with a zero pressure value obtained when the force transducer is displaced away from the membrane and without application of the known calibrating force, to form a force transducer characteristic which regulates all future force transducer measurements.
A method for calibrating a pressure sensor in situ within a living being for detecting a pressure (e.g., intracranial pressure (ICP), blood pressure, lung pressure, etc.) present at a location within the living being is disclosed. The method comprises: disposing a pressure sensor within the living being wherein the pressure sensor comprises a force transducer in contact with a flexible membrane, forming a portion of an outer surface of said pressure sensor, that is exposed to the pressure present at the location; coupling a capacitor to the flexible membrane; energizing the capacitor with a plurality of energy levels to apply corresponding known forces to the flexible membrane; and collecting the force transducer outputs corresponding to the applied known forces to generate a flexible membrane characteristic that is used to account for membrane stiffness which regulates all future force transducer measurements.
A method for calibrating a pressure sensor in situ within a living being for detecting a pressure (e.g., intracranial pressure (ICP), blood pressure, lung pressure, etc.) present at a location within the living being is disclosed. The method comprises: disposing a pressure sensor within the living being wherein the pressure sensor comprises a force transducer in contact with a flexible membrane, forming a portion of an outer surface of said pressure sensor, that is exposed to the pressure present at the location; displacing the force transducer away from the flexible membrane; collecting a force transducer output with the force transducer displaced out of contact with the flexible membrane to obtain a zero pressure value; applying at least one known calibrating force to the force transducer and collecting a corresponding force transducer output; and generating a force transducer characteristic from the zero pressure value and the corresponding force transducer output which regulates all future force transducer measurements.
A pressure sensor that is implantable within a living being for detecting a pressure (e.g., intracranial pressure (ICP), blood pressure, lung pressure, etc.) present at a location wherein the pressure sensor is implanted is disclosed. The implantable pressure sensor comprises: a housing comprising one side formed by a flexible membrane; wherein the housing further comprises sensor electronics including a displaceable force transducer in contact with the membrane for detecting flexing of the flexible membrane when the flexible membrane is exposed to the pressure present at the location. The flexible member comprises a known mass coupled thereto; wherein the sensor electronics further comprise a processor coupled to at least one detector for detecting the displacement of the mass when a known vibratory force is applied to the flexible membrane; and wherein the processor calculates a calibration force based on the displacement of the mass and time of displacement of the mass to form a force transducer characteristic which regulates all future force transducer measurements.
A method for calibrating a pressure sensor in situ within a living being for detecting a pressure (e.g., intracranial pressure (ICP), blood pressure, lung pressure, etc.) present at a location within the living being is disclosed. The method comprises: disposing a pressure sensor within the living being wherein the pressure sensor comprises a force transducer in contact with a flexible membrane, forming a portion of an outer surface of the pressure sensor, that is exposed to the pressure present at the location and wherein a known mass is coupled to the flexible membrane; applying a known vibratory force to the flexible membrane and collecting displacement data of the known mass; and generating a force transducer characteristic from the displacement data which regulates all future force transducer measurements.
The invention will be described in conjunction with the following drawings in which like reference numerals designate like elements and wherein:
The invention of the present application thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.
As shown in
The implantable pressure sensor 120 comprises a rigid housing 1 having an elastic or flexible membrane 5 that houses an electronics board 2, with a force transducer 3 disposed between the board 2 and the membrane 3. The sensor 120 comprises at least one capacitor (4A/4B or 4C/4D), each of which has one capacitor plate (4A and 4C) coupled to an inside surface of the membrane 3. The corresponding capacitor plates (4B and 4D) are attached to a surface of the electronics board 2 in alignment with their respective pairing capacitor plates, 4A and 4C. As will be discussed in detail later, when energized, these capacitors (4A/4B, 4C/4D) generate a force Fc that can push or pull the membrane 3; as a result, these capacitors are termed “capacitive actuators”. The implantable sensor 120 further comprises a charging device (CD) 6 that charges/discharges the capacitors 4A/4B and 4C/4D. As mentioned previously, the sensor 120 includes a communication mechanism (IT) 8 for wirelessly transmitting collected pressure data to the transceiver 122. As will be discussed in detail later, the communication format may include radio communication, infrared communication, etc., and the present invention is not limited to any particular communication methodology. It should be noted that the term “capacitor plate” can also be referred to as “electrode”.
The sensor 120 also comprises a battery BAT for powering force transducer electronics (ELEC) 7 the charging device 6 and the communication device IT 8. The battery BAT may be a rechargeable type, receiving a recharge signal from the remotely-located transceiver 122. It should be understood that the battery BAT is by way of example only and that the implantable sensor 120 may be a passive device that receives its electrical energy from the remotely-located transceiver 122 or other well-known external recharge device.
To effect the infrared communication, the side of the sensor housing 1 directly opposite the transmitter 8/receiver 9 pair comprises a transparent material (e.g., plexiglass) 10 that permits the passage of the infrared energy between the implantable sensor 120A and the infrared receiver 122A. By way of example only, when the implantable sensor 120A is to measure intracranial pressure (ICP), the sensor 120A is implanted within the subarachnoid space 11 of the test subject, as shown in
Again, as with the first embodiment 100, this embodiment 100A may comprise a battery that is rechargeable, or alternatively, this embodiment 100A may be a passive device, receiving all of its energy from the transceiver 122A.
It should be noted that the microcontroller 123 controls the operation of the sensor 120/120A, including the charging device 6, the transducer electronics 7, the capacitive actuators, the emitter LED 8 and, as will be discussed later, the actuator 144 and calibrating force member 148. Thus, all of these components, including the battery BAT are termed “sensor electronics”.
As mentioned earlier, implantable pressure sensor 120/120A is powered from the internal battery BAT or from the receiver 122/122A utilizing electromagnetic waves (RF or IR) transmitted through the skin, tissue and/or bone. The measured quantity, e.g., pressure, is detected using an active sensor principle where the energy from the measured quantity is amplified by the amplifier 125. In the preferred embodiment, information about the measured signal is converted to a frequency coded message and, for example, optically (e.g., infrared) transmitted outside the body to the receiver (see
One problem that this configuration encounters is the occasional occurrence of the output signal (i.e., the measured quantity signal 142) triggering the microcontroller 123 when the working wavelength of the “wake-up” signal 140 (e.g., transmitted infrared signal) and the measured quantity signal 142 (e.g., ICP signal) are the same. This problem is solved by two different methods. A first solution uses software whereby the microcontroller 123 overrides the wake up interruption signal 140 until the measured quantity signal 142 is sent; however this reduces the availability of ports in the microcontroller 123. A second solution is the use of two different wavelengths for signals 140 and 142 that do not interfere with one another. The latter solution is the preferred method since it takes advantage of some microcontroller inherent hardware benefits that prevents false triggering of the implantable sensor 120A.
A further embodiment 120B, as shown in
The present invention solves some of the problems usually associated with implantable sensors. It provides with an easy calibration method which lessens stability requirements and enables obtaining the correct measured value (e.g. ICP), even if sensor offset or sensor sensitivity is altered. The key is that the sensor can be calibrated in situ once implanted.
Once the sensor 120/120A is implanted within the living being, over time the membrane 5 is subjected to protein growths, among other things, and other factors that may cause the membrane to have a “stiffening” effect. As a result, there needs to be a way to account for that. To that end, the present invention 120-120A (
Thus, using capacitive actuators, multipoint calibration can be performed. The charge corresponding to certain force is applied F1C, F2C and F3C, and the output of the force transducer is measured. This process is repeated two or more times giving a series of input-output values corresponding to different forces generated by the capacitive actuators. This allows one to build a force output characteristic (see
Every sensor carries an inherent risk of drifting with time. While several compensation methods exist for external sensors, the drift problem is accentuated in the case of an implantable sensor. The active element of the sensor (e.g., piezoresistive element or die) changes its properties with time, temperature etc.
Moreover, changes in temperature produce changes in the pressure inside the sensor housing 120/120A. As shown most clearly in
Another source of drift might be related to sensor aging. However, the use of solid state components assures the longevity of the materials.
A typical solution to these problems is to utilize two identical sensors which respond to temperature and aging the same way. One sensor is usually exposed to the measured quantity while the reference one is only exposed to conditions inside the sensor housing. The resulting signal is calculated as a difference between the reference signal and the second sensor. However, this solution has several drawbacks: e.g., the reference pressure in the reference transducer has to be kept constant.
To address this concern, the present invention involves the following calibration technique on the force transducer. In particular, the method involves calibrating the sensor in-place before the measured quantity (e.g., ICP) reading is taken. This calibration technique assures that the parameters that affect the reading are taken into account and therefore their effects are nullified. The calibration method comprises four steps, as shown in
Step I involves having the force transducer 3 in contact with the membrane 5. Step II involves displacing the force transducer 3 away from membrane 5 so that it is out of contact with the membrane 5 and a force transducer output is taken; this is the “zero pressure force” measurement. Step III involves applying a calibration force (e.g., a known constant amplitude force; the force transducer measures each calibration force and then the corrected characteristic is calculated by the accompanying electronics ELEC 7) to the force transducer and then taking a reading; this is the “calibration force” measurement. From these two points, a force transducer characteristic can be generated for this particular force transducer. With the force transducer characteristic generated, Step IV is initiated which returns the force transducer into contact with the membrane 5, where the measured quantity (e.g., ICP) reading is taken.
The calibration force can be accomplished using any well-known mechanisms 148 (see
As shown in
While the invention has been described in detail and with reference to specific examples thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.
This PCT application claims the benefit under 35 U.S.C. §119(e) of Provisional Application Ser. No. 61/459,229 filed on Dec. 10, 2010 entitled IMPLANTABLE PRESSURE SENSOR and all of whose entire disclosure is incorporated by reference herein.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2011/063935 | 12/8/2011 | WO | 00 | 5/29/2013 |
Number | Date | Country | |
---|---|---|---|
61459229 | Dec 2010 | US |